Zhitong Finance App News, Sinopharm Holdings (01099) announced that Sinopharm achieved total operating revenue of about 55.066 billion yuan in the first three quarters of 2026, a year-on-year decrease of 0.11%; net profit attributable to shareholders of listed companies was about 952 million yuan, a year-on-year decrease of 0.48%; and basic earnings per share were 1.56 yuan. In the third quarter of 2026, we achieved operating income of 18.80 billion yuan, an increase of 2.57% year on year; net profit attributable to shareholders of listed companies was 346 million yuan, an increase of 18.91% year on year.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.